Opioid Rehab Near You: MAT, Detox & Recovery Programs
Browse SAMHSA-listed opioid rehab programs across all 50 states — filter by MAT type (buprenorphine, methadone, naltrexone), level of care (OTP, OBOT, residential, IOP, telehealth), and insurance acceptance. MAT reduces opioid overdose deaths by more than 50% (NIDA), yet fewer than 20% of people with OUD receive it. Synthetic opioids (primarily fentanyl) drive ~75% of US opioid overdose deaths — CDC reports over 80,000 annually. After the 2023 MAT Act, any licensed prescriber can offer buprenorphine in office-based or telehealth settings.
Found 9,319 rehab centers specializing in opioid addiction across the United States.
Need Help Finding the Right Treatment Center?
Speak with a compassionate specialist now - 100% free & confidential
Find Opioid Treatment Centers Near You
Browse opioid treatment centers below. Filter by MAT availability, state, insurance, and level of care to find the right program for your recovery needs.
Showing 20 of 9319 results
Fairfax Methadone Treatment Center in Annandale, VA, provides a range of outpatient services for adults and young adults, including methadone/buprenorphine or naltrexone therapy and general substance use treatment. They employ individualized approaches such as anger management, brief intervention, and cognitive behavioral therapy to meet each client's unique needs. The center also offers distinct programs designed for male and female patients, ensuring comprehensive support for everyone. Their dedication to high-quality, personalized care makes Fairfax Methadone Treatment Center a leading provider of effective and caring addiction recovery services in Annandale.
FMRS Health Systems Inc, located in Beckley, WV, provides extensive care for individuals of all ages facing challenges with addiction and mental health conditions. This center offers inpatient hospital detox and therapeutic interventions, including anger management techniques, brief intervention strategies, and cognitive behavioral therapy. FMRS Health Systems Inc features dedicated programs for teenagers, adult men, and adult women, accommodating varied age groups. A key strength of FMRS Health Systems Inc is its expertise in treating dual diagnoses, delivering personalized support for those with severe mental health concerns. This establishment, known for its supportive atmosphere and high standard of care, serves as a vital resource for individuals on their journey to wellness.
The Fairfax/Falls Church Comm Servs Board in Chantilly, VA provides extensive residential treatment for adults dealing with substance use and severe mental health challenges, along with addressing significant emotional disturbances in children. This center operates around the clock, utilizing methods such as motivational interviewing, relapse prevention, and counseling specific to substance use disorders. Customized programs are designed for adult men and women, accommodating individuals of all ages and genders. With a commitment to delivering high-quality care, this facility excels in offering a wide range of services and specialized programs, positioning it as an outstanding option for those in need of individualized rehabilitation assistance.
FMRS Health Systems Inc, located in Fayetteville, WV, specializes in outpatient treatment for adults dealing with substance use issues alongside serious mental health disorders, as well as children experiencing significant emotional challenges. The facility features targeted programs for teens and young adults, employing methods such as anger management, brief interventions, and cognitive behavioral therapy. Offering outpatient options with medications like methadone/buprenorphine and naltrexone, this center serves both men and women. FMRS Health Systems Inc is distinguished by its thorough treatment protocols and personalized recovery plans for both adults and youth.
Face to Face Mental Health Servs in Miami, Florida offers regular outpatient substance use treatment for children, adolescents, and adults. Naltrexone is used in treatment, and programs serve adolescents, seniors, and clients with co-occurring mental or pain disorders. Medicaid, Medicare, TRICARE, and a sliding fee scale are accepted, with services in Spanish, Creole, and Italian.
Residential substance use treatment in Eau Claire, WI, on both short-term and long-term tracks, with buprenorphine available. Fahrman Center serves adult women, pregnant and postpartum women, adult men, criminal justice clients, and trauma survivors. Medicaid, self-payment, SAMHSA block grants, and federal treatment funding are accepted.
Situated in New Haven, CT, Fair Haven Community Healthcare delivers a wide range of outpatient services tailored for adults and seniors who are pursuing substance use treatment. The center excels in addressing co-occurring substance use disorders in conjunction with significant mental health challenges or emotional issues in children. Emphasizing a personalized approach, this facility offers programs such as 12-step facilitation, anger management, and brief interventions. Fair Haven Community Healthcare provides outpatient treatments with methadone, buprenorphine, or naltrexone for both men and women. Patients can anticipate receiving top-notch, individualized support throughout their recovery process.
Fairfax Behavioral Health in Kirkland, Washington, operates a hospital-based program with inpatient detoxification and inpatient treatment, plus intensive and regular outpatient care, for adolescents through seniors. Buprenorphine and naltrexone are used in treatment, and a track serves active duty military. Medicare, Medicaid, and TRICARE are among the payment options.
FCC Behavioral Health, situated in Piedmont, MO, provides focused outpatient care for adults struggling with substance use disorders and co-occurring severe mental health conditions, as well as for children experiencing emotional disturbances. Their therapeutic offerings encompass anger management, cognitive behavioral therapy, and brief intervention strategies. Recognizing the unique needs of various groups, FCC Behavioral Health offers specialized programs for active duty military personnel, adolescents, and adult men. They deliver outpatient treatment using methadone, buprenorphine, or naltrexone, ensuring high-quality services for adults and young individuals of all genders. For those in search of impactful addiction recovery within a nurturing setting, FCC Behavioral Health offers thorough and individualized support.
FMRS Health Systems Inc, located in Hinton, WV, specializes in outpatient treatment for substance use disorders for both adults and children/adolescents facing concurrent significant mental health challenges. The center employs methods including anger management, brief intervention, and cognitive behavioral therapy, ensuring that each client receives care specifically designed for their unique needs. Committed to a personalized approach, the center supports male and female clients in their journey toward recovery. FMRS Health Systems Inc distinguishes itself as an all-encompassing rehabilitation facility by prioritizing high-quality care and tailored treatment for individuals dealing with serious emotional issues, guiding them toward sustainable recovery.
Fair Haven Community Healthcare, located in New Haven, CT, specializes in outpatient services for adults dealing with substance use and concurrent mental health issues, as well as addressing emotional challenges faced by children. The center caters to specific groups such as active military members, teenagers, and adult males. Treatment methods offered include cognitive behavioral therapy, anger management sessions, and short-term interventions. The facility is committed to providing tailored services to adults and seniors of all genders, offering outpatient alternatives such as methadone, buprenorphine, or naltrexone, along with ongoing therapy. Fair Haven Community Healthcare prioritizes a holistic and personalized treatment approach, striving to assist individuals on their journey to recovery.
FCRC of Ohio, also known as Family Counseling and Rehabilitation, operates in Marietta, Ohio with hospital inpatient care plus outpatient day treatment and intensive outpatient programs. Buprenorphine and naltrexone are used. Services cover pregnant and postpartum women and clients with trauma histories, from adolescents through seniors, with Medicaid and sliding fees accepted.
Fair Oaks Pavilion, situated in Delray Beach, FL, delivers extensive inpatient detoxification for adults and young adults within a hospital environment. Utilizing 12-step facilitation, anger management techniques, and brief intervention strategies, the center serves adult men and women, including those facing dual diagnoses of mental health and substance use conditions. The facility offers tailored care for both male and female patients, fostering a welcoming and inclusive atmosphere. Fair Oaks Pavilion is committed to providing effective treatment to aid individuals in conquering addiction and attaining sustained sobriety.
The Fairbanks Native Association, situated in Fairbanks, Alaska, delivers comprehensive substance use disorder care for individuals of all ages. They excel in addressing dual diagnoses of addiction and severe mental health conditions, offering intensive outpatient, long-term residential, and standard outpatient services. Their therapeutic approach incorporates anger management, brief intervention strategies, and cognitive behavioral therapy, serving adult men and women, alongside adolescent clients. The Fairbanks Native Association is dedicated to providing effective recovery support in a nurturing setting, making it a reliable option for those in need of rehabilitation.
FCC Behavioral Health in Poplar Bluff, MO, delivers targeted substance abuse care for adults managing significant mental health conditions alongside their addiction. The facility offers intensive outpatient and standard outpatient services, incorporating medication-assisted treatment with methadone, buprenorphine, or naltrexone. Employing strategies like motivational interviewing and relapse prevention, the center centers its approach on counseling for substance use disorders. Catering to adult men, adult women, and young adults, FCC Behavioral Health prioritizes personalized treatment plans. The center's dedication to gender-specific programming and a full spectrum of support makes it a leading option for effective addiction recovery in the area.
FCC Behavioral Health, situated in West Plains, MO, provides thorough addiction recovery services for adults managing co-occurring severe mental health conditions and for children facing significant emotional challenges. Their therapeutic offerings encompass intensive outpatient care, extended residential stays, and standard outpatient services. The facility excels in 12-step integration, anger resolution techniques, and brief intervention strategies. Distinctive programs are available for teenagers, survivors of trauma, and individuals grappling with combined mental health and substance abuse issues. Committed to high standards of care, FCC Behavioral Health delivers targeted interventions for male and female patients within a nurturing setting.
FCC Behavioral Health in Caruthersville, MO provides accessible outpatient treatment for adults grappling with substance use disorders. They also offer targeted support for adults with co-occurring substance use and serious mental health conditions, as well as children experiencing emotional disturbances. Treatment modalities include medication-assisted options such as methadone, buprenorphine, or naltrexone, alongside standard outpatient services. The center utilizes evidence-based approaches including 12-step facilitation, anger management techniques, and brief intervention strategies. Dedicated programs are available for active duty military personnel, adolescents, and adult men. FCC Behavioral Health is committed to delivering personalized and effective care to adults and young people of all genders, fostering paths to recovery.
FCC Behavioral Health in West Plains, MO provides customized recovery programs for individuals facing substance use and mental health challenges. They offer intensive outpatient, regular outpatient, and day treatment services for adults and young adults. The center emphasizes approaches like 12-step facilitation, anger management, and brief intervention. Distinctive offerings include specialized support for survivors of sexual abuse or trauma and for those with dual diagnoses. FCC Behavioral Health is dedicated to delivering high-quality care to both men and women on their journey to wellness.
FMRS Health Systems Inc, situated in Union, WV, provides targeted outpatient services for individuals dealing with substance use and co-existing mental health issues, catering to both adults and young clients. The center employs various methods including anger management, brief interventions, and cognitive behavioral therapy, ensuring that care is personalized for each individual. FMRS Health Systems Inc prioritizes a tailored strategy to accommodate the specific needs of both male and female clients in search of effective rehabilitation solutions. The comprehensive programs offered here are designed to foster enduring recovery and enhance mental well-being for everyone, from adults to children and adolescents.
FOCUS House, situated in Lawrenceburg, IN, provides a wide range of rehabilitation solutions for those facing challenges related to substance use disorders alongside mental health issues. The center offers various treatment options including intensive outpatient, long-term residential, and standard outpatient programs. Methods employed here include 12-step facilitation, anger management strategies, and brief interventions. FOCUS House caters to adult men and women, young adults, and those who have endured trauma. Committed to delivering high-quality care and personalized assistance, the center aims to empower individuals on their journey to sustainable recovery and overall wellness.
Opioid Use Disorder (OUD): Key Facts
Classification
Opioid Use Disorder (OUD)
Prevalence
2.1 million adults with OUD in the US (SAMHSA)
Overdose deaths
80,000+ opioid overdose deaths/year in US (CDC)
Primary substances
Fentanyl, heroin, oxycodone, hydrocodone
Gold standard treatment
Medication-Assisted Treatment (MAT)
MAT effectiveness
Reduces overdose deaths by 50%+ (NIDA)
FDA-approved medications
Buprenorphine (Suboxone), Methadone, Naltrexone (Vivitrol)
Emergency reversal
Naloxone (Narcan)
Opioid Overdose Emergency: Know the Signs
An opioid overdose can kill within minutes. If you see these signs, act immediately:
Overdose warning signs
- Blue or purple lips and fingernails (cyanosis)
- Pinpoint (extremely small) pupils
- Slow, shallow, or stopped breathing
- Unresponsive to shouting or sternal rub
- Gurgling or choking sounds
- Limp body, pale or clammy skin
What to do
- Call 911 immediately — most states have Good Samaritan laws protecting callers
- Administer naloxone (Narcan) if available — nasal spray or injection
- Perform rescue breathing — one breath every 5 seconds
- Place in recovery position (on their side) to prevent choking
- Give a second dose of naloxone after 2-3 minutes if no response
- Stay until help arrives — naloxone wears off in 30-90 minutes
National Overdose Prevention Hotline: 911 | SAMHSA Helpline: 1-800-662-4357 (24/7, free, confidential)
What Is Opioid Use Disorder?
DSM-5 diagnostic criteria
Opioid Use Disorder (OUD) is a chronic, relapsing brain condition defined by the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). It is diagnosed when a person meets at least two of eleven criteria within a 12-month period, including: taking opioids in larger amounts or for longer than intended, persistent desire or unsuccessful efforts to cut down, spending excessive time obtaining or using opioids, cravings, failure to fulfill major obligations, continued use despite social or interpersonal problems, giving up important activities, use in physically hazardous situations, continued use despite physical or psychological problems, tolerance, and withdrawal.
Severity classification
OUD severity is classified based on the number of criteria met: mild (2-3 criteria), moderate (4-5 criteria), and severe (6 or more criteria). Severe OUD carries the highest risk of overdose death and typically requires the most intensive treatment, including medication-assisted treatment. Even mild OUD warrants professional intervention, as the disorder tends to progress without treatment.
Opioids vs. opiates
The term "opiates" refers specifically to natural compounds derived from the opium poppy (morphine, codeine). "Opioids" is the broader term that includes opiates plus semi-synthetic drugs (oxycodone, hydrocodone, heroin) and fully synthetic drugs (fentanyl, methadone, tramadol). All opioids bind to mu-opioid receptors in the brain, producing pain relief, euphoria, and respiratory depression — the mechanism that causes fatal overdoses.
The Opioid Epidemic: Fentanyl Crisis
Three waves of the opioid epidemic
The US opioid crisis has unfolded in three distinct waves. The first wave (1990s) was driven by aggressive marketing of prescription opioids — OxyContin, Vicodin, Percocet — leading doctors to overprescribe and millions of patients to develop dependence. The second wave (around 2010) saw a surge in heroin use as people with prescription opioid addiction shifted to cheaper, more accessible heroin. The third wave (2013-present) is defined by illicitly manufactured fentanyl and its analogs, which now account for the majority of opioid overdose deaths in the United States.
Why fentanyl changed everything
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine and approximately 50 times more potent than heroin. A lethal dose of fentanyl is just 2 milligrams — roughly the size of a few grains of salt. Because fentanyl is cheap to manufacture and extremely potent by weight, drug traffickers mix it into heroin, cocaine, methamphetamine, and counterfeit prescription pills. Many people who die from fentanyl overdoses did not know they were consuming it. Counterfeit pills made to look like oxycodone (M30), Xanax, or Adderall frequently contain lethal doses of fentanyl.
Current impact
According to the CDC, over 80,000 Americans die from opioid overdoses each year, with synthetic opioids (primarily illicit fentanyl) responsible for roughly 75% of those deaths. Opioid overdose is now the leading cause of accidental death for Americans under 50. The crisis affects every demographic, geographic region, and socioeconomic group in the country.
Opioid Withdrawal Timeline
Opioid withdrawal is intensely uncomfortable but rarely life-threatening on its own. The timeline varies depending on whether the person was using short-acting opioids (heroin, oxycodone, hydrocodone) or long-acting opioids (methadone, extended-release morphine).
Short-acting opioids (heroin, oxycodone)
- 6-12 hours: Onset of symptoms — anxiety, muscle aches, sweating, yawning, runny nose
- 24-48 hours: Escalation — insomnia, diarrhea, nausea, vomiting, abdominal cramps, dilated pupils
- 48-72 hours: Peak severity — intense cravings, body aches, goosebumps, rapid heartbeat
- 5-7 days: Acute symptoms begin to subside
- 1-2 weeks: Most physical symptoms resolve
Long-acting opioids (methadone, ER morphine)
- 24-48 hours: Delayed onset of symptoms
- 3-5 days: Symptoms escalate and peak
- 5-10 days: Peak and plateau of acute withdrawal
- 10-20 days: Gradual improvement of physical symptoms
- 2-3 weeks: Most acute symptoms resolve
Post-Acute Withdrawal Syndrome (PAWS)
After acute withdrawal resolves, many people experience Post-Acute Withdrawal Syndrome (PAWS) — a set of prolonged symptoms including anxiety, depression, insomnia, fatigue, difficulty concentrating, and mood swings that can persist for weeks to months. PAWS is the leading cause of relapse in the first year of recovery and is a key reason why ongoing treatment and support are essential after detox.
Why medical detox matters
While opioid withdrawal itself is rarely fatal, the extreme discomfort drives many people to relapse during detox — and relapse after a period of abstinence is when overdose risk is highest, because tolerance has decreased. Medically supervised detoxification uses medications like buprenorphine, clonidine, and comfort medications to manage symptoms safely, dramatically reducing relapse during the withdrawal period.
Medication-Assisted Treatment (MAT)
Medication-Assisted Treatment is the gold standard for opioid use disorder, combining FDA-approved medications with counseling and behavioral therapies. Research from NIDA shows MAT reduces opioid overdose deaths by more than 50%, decreases illicit opioid use, reduces criminal activity, improves social functioning, and increases treatment retention. Despite this evidence, fewer than 20% of people with OUD receive MAT — a treatment gap that costs tens of thousands of lives each year.
Buprenorphine (Suboxone)
Type: Partial opioid agonist
Buprenorphine activates opioid receptors just enough to prevent withdrawal and cravings without producing the intense euphoria of full agonists. It has a "ceiling effect," meaning higher doses do not increase effects — significantly reducing overdose risk. Suboxone combines buprenorphine with naloxone to deter misuse.
Setting: Can be prescribed by any licensed prescriber in office-based settings (OBOT), pharmacies, or telehealth.
Methadone
Type: Full opioid agonist
Methadone is a long-acting opioid that stabilizes brain chemistry, eliminates withdrawal symptoms, and blocks the euphoric effects of other opioids at proper doses. It has the longest track record of any MAT medication, with over 50 years of evidence supporting its effectiveness.
Setting: Must be dispensed daily at a certified Opioid Treatment Program (OTP/methadone clinic). Take-home doses earned over time with compliance.
Naltrexone (Vivitrol)
Type: Opioid antagonist (blocker)
Naltrexone completely blocks opioid receptors, preventing any opioid from producing effects. The extended-release injection (Vivitrol) is administered monthly and eliminates the need for daily medication adherence. Unlike buprenorphine and methadone, naltrexone has no abuse potential and is not a controlled substance.
Requirement: Patient must be fully detoxed (7-14 days opioid-free) before starting naltrexone to avoid precipitated withdrawal.
MAT medication comparison
The three FDA-approved MAT medications differ in mechanism, dispensing model, and patient fit. The table below summarizes the key distinctions:
| Medication | Type | DEA Schedule | Setting | Dispensing | Best for |
|---|---|---|---|---|---|
| Buprenorphine (Suboxone, Sublocade, Subutex, Zubsolv, Brixadi) | Partial agonist with ceiling effect | III | OBOT, telehealth, retail pharmacy | Take-home from day 1 (or monthly injection) | Most patients; rural areas; daily clinic not feasible |
| Methadone | Full mu-opioid agonist | II | OTP only (42 CFR Part 8) | Daily at clinic → take-home after 90 days | Severe OUD; prior buprenorphine failure; long-standing dependence |
| Naltrexone (Vivitrol) | Opioid antagonist (blocker) | Not controlled | Any prescriber; injection at clinic | Monthly IM injection (380 mg) | Highly motivated; post-detox (7-14 days opioid-free); no abuse potential desired |
All three are effective; the best choice is the one the patient will actually take consistently. Adherence, not pharmacology, is the dominant predictor of outcomes. Buprenorphine and methadone are first-line for active opioid use; naltrexone requires complete detox before initiation.
Types of Opioid Treatment Programs
OTP / Methadone Clinics
Opioid Treatment Programs are federally certified clinics that dispense methadone and provide comprehensive services including counseling, drug testing, and case management. Patients visit daily initially, earning take-home privileges over time.
OBOT (Office-Based Treatment)
Office-Based Opioid Treatment allows any licensed prescriber to treat OUD with buprenorphine in a standard medical office or via telehealth. This model dramatically increases access, especially in rural areas with no OTPs. Patients fill prescriptions at regular pharmacies.
Residential (inpatient) programs provide 24/7 structured care for 30-90 days. Best for severe OUD, polysubstance use, co-occurring mental health disorders, or patients who need separation from their environment. Most residential programs offer MAT as part of treatment.
IOP programs provide 9-20 hours of structured treatment per week while allowing patients to live at home. Combines group therapy, individual counseling, and MAT. Effective for moderate OUD or as a step-down from residential treatment.
Standard outpatient involves 1-2 sessions per week — typically individual therapy and/or group sessions combined with MAT. Suitable for mild to moderate OUD or as a long-term maintenance level of care after completing more intensive treatment.
Medical detox provides 3-7 days of supervised withdrawal management using medications to ease symptoms. Detox alone is not treatment — it must be followed by ongoing MAT and/or behavioral therapy. Detox without continued care has very high relapse rates.
Naloxone: The Overdose Reversal Medication
What naloxone does
Naloxone (brand name Narcan) is an opioid antagonist that rapidly reverses opioid overdose by displacing opioids from receptors in the brain. It restores normal breathing within 2-5 minutes in most cases. Naloxone has no effect on people who do not have opioids in their system and has virtually no abuse potential. Since 2023, Narcan nasal spray is available over the counter at pharmacies nationwide without a prescription.
How to use naloxone nasal spray
Using Narcan nasal spray requires no medical training:
- Peel back the package and remove the device
- Tilt the person's head back and insert the nozzle into one nostril
- Press the plunger firmly to deliver the full dose
- If no response in 2-3 minutes, administer a second dose in the other nostril
- Continue rescue breathing and call 911 — naloxone wears off in 30-90 minutes, and the person may stop breathing again
Where to get naloxone for free
Many harm reduction organizations, health departments, and community pharmacies distribute naloxone for free or at low cost. SAMHSA's Opioid Overdose Prevention Toolkit and state naloxone access programs provide resources. Most states have standing orders allowing pharmacists to dispense naloxone without an individual prescription. If you or someone you know uses opioids, carrying naloxone can save a life.
Frequently Asked Questions About Opioid Treatment
What is medication-assisted treatment (MAT) for opioid addiction?
Medication-Assisted Treatment (MAT) combines FDA-approved medications — methadone, buprenorphine (Suboxone), or naltrexone (Vivitrol) — with counseling and behavioral therapies. These medications reduce cravings, prevent withdrawal symptoms, and normalize brain chemistry, allowing people to focus on recovery. MAT is the most effective treatment for opioid use disorder: it reduces overdose deaths by more than 50%, decreases illicit drug use, and improves treatment retention rates (NIDA).
How long does opioid withdrawal last?
The withdrawal timeline depends on the opioid used. Short-acting opioids like heroin and oxycodone cause symptoms within 6-12 hours that peak at 48-72 hours and subside over 5-7 days. Long-acting opioids like methadone produce delayed symptoms starting at 24-48 hours, peaking at 3-5 days, and lasting up to 2-3 weeks. Post-acute withdrawal symptoms (PAWS) — including anxiety, insomnia, and mood instability — may persist for weeks to months after acute withdrawal resolves.
Is buprenorphine (Suboxone) just replacing one addiction with another?
No — this is one of the most harmful misconceptions in addiction medicine. Buprenorphine is a partial opioid agonist prescribed at stable, controlled doses as part of comprehensive treatment. It does not produce euphoria when taken as directed, eliminates cravings, prevents withdrawal, and allows people to function normally — work, care for families, and rebuild their lives. Taking buprenorphine for OUD is no different than taking insulin for diabetes: it is evidence-based medication for a chronic medical condition.
What should I look for in an opioid treatment center?
Look for centers offering MAT options (buprenorphine, methadone, and/or naltrexone), accreditation from CARF or The Joint Commission, licensed medical staff experienced in addiction medicine, comprehensive assessment with individualized treatment plans, evidence-based therapies (CBT, contingency management), family support services, and strong aftercare planning. Verify they accept your insurance and offer the appropriate level of care for your situation.
Can I work while in opioid treatment?
Yes, especially with outpatient MAT programs. Outpatient treatment — including OBOT (office-based buprenorphine) and standard outpatient counseling — allows you to maintain work, family, and social responsibilities while receiving care. Intensive Outpatient Programs (IOP) typically meet 9-20 hours per week and can often be scheduled around work. Many employers are required to support recovery under the ADA and FMLA. Residential treatment requires time away but provides the most intensive support for severe cases.
What is fentanyl and why is it so dangerous?
Fentanyl is a fully synthetic opioid that is 50-100 times more potent than morphine. A lethal dose is just 2 milligrams. It is increasingly found in the illicit drug supply, mixed into heroin, cocaine, methamphetamine, and counterfeit prescription pills — often without the user's knowledge. Fentanyl is now responsible for roughly 75% of all opioid overdose deaths in the United States. Treatment for fentanyl addiction typically requires MAT (often at higher buprenorphine or methadone doses), naloxone training, and comprehensive behavioral support.
How long does MAT treatment last?
There is no fixed duration for MAT — treatment length should be individualized. Research consistently shows that longer treatment produces better outcomes. The American Society of Addiction Medicine (ASAM) recommends a minimum of one year of MAT, and many addiction specialists recommend indefinite maintenance for people with severe OUD, as the risk of fatal overdose is highest in the period after discontinuing MAT. The decision to taper off medication should be made collaboratively with a treatment provider when the patient is stable, has strong support systems, and is not facing major life stressors.
Is fentanyl in the drug supply near me?
Almost certainly yes. Fentanyl has been detected in the illicit drug supply in all 50 states. It is routinely found in heroin, counterfeit prescription pills (especially fake oxycodone M30s, Xanax, and Adderall), cocaine, and methamphetamine. DEA lab testing shows that 7 out of 10 counterfeit pills seized contain a potentially lethal dose of fentanyl. Fentanyl test strips — which can detect fentanyl before use — are available for free from many harm reduction organizations, health departments, and community pharmacies. The safest assumption is that any illicit substance may contain fentanyl.
Medical Review and Sources
Trusted Resources
Substance Abuse and Mental Health Services Administration
Federal agency providing information, resources, and treatment locator for substance abuse and mental health.
Helpline: 1-800-662-4357
National Institute on Drug Abuse
NIH institute advancing science on drug use and addiction causes, consequences, and treatment.
National Institute on Alcohol Abuse and Alcoholism
NIH institute supporting research on alcohol's impact on health and providing treatment resources.
Ready To Start Opioid Treatment?
Opioid addiction is a medical condition — not a moral failure. Medication-assisted treatment saves lives. Speak with a specialist who can help you find the right MAT program, detox center, or residential facility — 100% free and confidential, available 24/7.
Browse opioid addiction programs in states with the most treatment options.
Related conditions, treatment approaches, and levels of care.